Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.02 USD | +3.67% | +5.28% | -33.01% |
Apr. 23 | Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32 | MT |
Apr. 18 | AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.01% | 1.12B | |
-2.01% | 187B | |
-1.81% | 106B | |
-3.99% | 66.9B | |
+0.49% | 49.45B | |
+16.76% | 48B | |
+4.06% | 40.84B | |
+3.45% | 26.48B | |
+2.20% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ATRC Stock
- News AtriCure, Inc.
- UBS Adjusts AtriCure Price Target to $58 From $57, Maintains Buy Rating